Skip to main content

Table 3 Proportion of ART facilities that met WHO EWI targets, aggregated by additional programmatic/ facility characteristics, Tanzania, 2010

From: Monitoring prevention or emergence of HIV drug resistance: results of a population-based foundational survey of early warning indicators in mainland Tanzania

  

EWI 1a, ART prescribing practices

EWI 2, patients LTFU at 12 months

EWI 3a, retention on 1st line ART at 12 months

EWI 5b, Clinic appointment keeping in first 12 months

  

WHO target: 100%

WHO target: ≤ 20%

WHO target: ≥ 70%

WHO target: ≥ 80%

 

Frequency

n (%)

n (%)

n (%)

n (%)

Average opening time (hours)

  Clinic & pharmacy: ≥ 8 hrs

29

29 (100)

16 (55)

10 (35)

0 (0)

  Clinic & pharmacy: < 8 hrs

6

6 (100)

1 (17)

0 (0)

1 (17)

   

p = 0.177

p = 0.640

p = 0.171

Average distance (kilometers, km) travelled by patient

  ≥ 51 km

10

10 (100)

5 (50)

3 (30)

1 (10)

  21-50 km

10

10 (100)

5 (50)

3 (30)

0 (0)

  11-20 km

8

8 (100)

6 (75)

3 (38)

0 (0)

  ≤ 10 km

7

7 (100)

1 (14)

1 (14)

0 (0)

   

p = 0.162

p = 0.885

p = 1.000

Average time (minutes) patient spent at the Clinic

  >180 minutes

6

6 (100)

6 (100)

5 (83)

0 (0)

  60-180 minutes

15

15 (100)

7 (47)

3 (20)

1 (7)

  < 60 minutes

14

14 (100)

4 (29)

2 (14)

0 (0)

   

p = 0.011*

p = 0.007*

p = 1.000

Supplementary ART dispensing locations

  Refill, outreach or both

5

5 (100)

2 (40)

2 (40)

0 (0)

  Neither

30

30 (100)

15 (50)

8 (27)

1 (3)

   

p = 1.000

p = 0.610

p = 1.000

Home based services

  Yes

25

25 (100)

13 (52)

6 (24)

1 (4)

  No

10

10 (100)

4 (40)

4 (40)

0 (0)

   

p = 0.711

p = 0.421

p = 1.000

  1. *Statistically significant.
  2. EWI 1a, % of adult patients initiating ART at the site* who are initially prescribed, or who initially pick up from the pharmacy, an appropriate first-line ART regimen.
  3. EWI 2, % of patients initiating ART at the site* who are lost to follow-up (LTFU) 12 months after ART initiation.
  4. EWI 3a, % of adult patients initiating ART at the site* who are taking an appropriate first-line ART regimen 12 months later.
  5. EWI 5b, % of patients initiating ART at the site* who attended all scheduled or expected clinical consultations on time during the first 12 months.